Dr. Reddys Laboratories Ltd.

United States Food & Drug Administration (USFDA) has completed a GMP inspection at Dr. Reddy's Laboratories’ formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad. The inspection was conducted from August 6, 2026 to August 14, 2026. The company has been issued a Form 483 with four observations, which we will address within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.